About Regeneron: Innovative Pharmaceutical Research and Development
Robbins LLP has initiated a class action lawsuit against Regeneron Pharmaceuticals, Inc., alleging the company made false or misleading statements regarding its business practices and drug commercialization. Investors claim these ... Read More